Session » Metabolic and Crystal Arthropathies Poster II
-
Abstract Number: 2340
Improvement in Treat to Target Serum Urate Levels: Preliminary Results from a Comparison Between Two Audits of Management
-
Abstract Number: 2341
Treatment of Gout with Pharmacological Vs. Non-Pharmacological Complementary Therapy in the U.S.: An Internet Survey
-
Abstract Number: 2342
Uric Acid-Lowering Therapy Management Among Rural Veterans Affairs Primary Care Providers
-
Abstract Number: 2343
Impact of Colchicine Use on the Development of Incident Coronary Artery Disease
-
Abstract Number: 2344
A 3-Year Follow-up Study of Canakinumab in Frequently Flaring Gouty Arthritis Patients, Contraindicated, Intolerant, or Unresponsive to Nonsteroidal Anti-Inflammatory Drugs and/or Colchicine
-
Abstract Number: 2345
Canakinumab Liquid Formulation in Acute Gouty Arthritis Patients: Long-Term Safety and Efficacy Results from a 36-Week Extension Study
-
Abstract Number: 2346
Rebamipide Suppresses Monosodium Urate Crystal-Induced Interleukin-1b Production through Regulation of Oxidative Stress and Caspase-1 in THP-1 Cells
-
Abstract Number: 2347
Can We Predict the Dose of Allopurinol to Achieve Target Urate?
-
Abstract Number: 2349
The Efficacy and Tolerability of Febuxostat in Hyperuricemic Patients with Severe Renal Impairment
-
Abstract Number: 2350
Efficacy and Safety of Febuxostat in 55 Gouty Patients with Stage 4/5 Chronic Kidney Disease: Results from a Retrospective Multicenter Study
-
Abstract Number: 2351
A Study to Evaluate the Pharmacodynamics, Pharmacokinetics and Safety of Arhalofenate in Combination with Febuxostat When Treating Hyperuricemia Associated with Gout
-
Abstract Number: 2352
Efficacy and Safety in Patients with Tophaceous Gout Receiving Lesinurad and Febuxostat Combination Therapy: Interim Analysis of an Extension Study
-
Abstract Number: 2353
Lesinurad and Febuxostat Combination Therapy: Analysis of Treatment Based on Patient Baseline Renal Function
-
Abstract Number: 2354
The Safety and Efficacy of Lower Serum Urate Levels: A Pooled Analysis of Gout Subjects Receiving Lesinurad and Xanthine Oxidase Inhibitors
-
Abstract Number: 2355
Effects of the Dietary Approaches to Stop Hypertension (DASH) Diet on Serum Uric Acid Levels: A Randomized Controlled Trial